Article
Myogenic Precursors from iPS Cells for Skeletal Muscle Cell Replacement Therapy
29 Jan 2015
Abstract excerpt
The use of adult myogenic stem cells as a cell therapy for skeletal muscle regeneration has been attempted for decades, with only moderate success. Myogenic progenitors (MP) made from induced pluripotent stem cells (iPSCs) are promising candidates for stem cell therapy to regenerate skeletal muscle since they allow allogenic transplantation, can be produced in large quantities, and, as compared to adult...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
